MaxCyte, Inc. (MXCT)
NASDAQ·Healthcare·Biotechnology
$1.69
+9.42%
Mkt Cap $147.59M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+256.1%
Consensus $6.00 vs current $1.69
NASDAQ·Healthcare·Biotechnology
$1.69
+9.42%
Mkt Cap $147.59M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+256.1%
Consensus $6.00 vs current $1.69